Injectable Spacer Reduces Radiotherapy Consequences
By HospiMedica International staff writers Posted on 24 Jun 2015 |
Image: The SpaceOAR system benefits (Photo courtesy of Augmenix).
A novel spacer separates the rectum from the prostate during radiotherapy (RT), potentially reducing the risk of adjacent organ-at-risk (OAR) injury.
The SpaceOAR system is a temporary injectable gel that protects the rectum in men undergoing RT for prostate cancer. The hydrogel, which is created from a mixture of two separate syringes, is injected through the perineum, guided by transrectal ultrasound. The material flows into the space between the prostate and the rectum and expands within ten seconds, filling the space and reducing rectum radiation during prostate RT. The hydrogel remains in place for three months, and is then liquefied and absorbed, leaving nothing behind.
Because the prostate gland is located close to the bladder and rectum, it is important for RT to be tightly focused on the prostate to avoid serious side effects to surrounding organs, such as bleeding, diarrhea, and pain. Shielding the rectum from radiation also permits dose escalation and hypo-fractionation, resulting in more prostate radiation, improved cancer kill rates, and fewer radiation treatment sessions. The SpaceOAR system is a product of Augmenix (Waltham, MA, USA), and has been approved by the US Food and Drug Administration (FDA).
“For years, hydrogel products have been used safely to protect the most sensitive parts of the body as sealants and adhesion barriers, and now prostate cancer patients will also be able to benefit,” said John Pedersen, CEO of Augmenix. “FDA clearance of the SpaceOAR System represents a significant development in advancing the safety, precision, and flexibility with which prostate cancer radiotherapy can be delivered.”
Related Links:
Augmenix
The SpaceOAR system is a temporary injectable gel that protects the rectum in men undergoing RT for prostate cancer. The hydrogel, which is created from a mixture of two separate syringes, is injected through the perineum, guided by transrectal ultrasound. The material flows into the space between the prostate and the rectum and expands within ten seconds, filling the space and reducing rectum radiation during prostate RT. The hydrogel remains in place for three months, and is then liquefied and absorbed, leaving nothing behind.
Because the prostate gland is located close to the bladder and rectum, it is important for RT to be tightly focused on the prostate to avoid serious side effects to surrounding organs, such as bleeding, diarrhea, and pain. Shielding the rectum from radiation also permits dose escalation and hypo-fractionation, resulting in more prostate radiation, improved cancer kill rates, and fewer radiation treatment sessions. The SpaceOAR system is a product of Augmenix (Waltham, MA, USA), and has been approved by the US Food and Drug Administration (FDA).
“For years, hydrogel products have been used safely to protect the most sensitive parts of the body as sealants and adhesion barriers, and now prostate cancer patients will also be able to benefit,” said John Pedersen, CEO of Augmenix. “FDA clearance of the SpaceOAR System represents a significant development in advancing the safety, precision, and flexibility with which prostate cancer radiotherapy can be delivered.”
Related Links:
Augmenix
Latest Surgical Techniques News
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons